NIH Guide: Weekly Index for May 22, 2020

Funding Opportunities

• Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
  (PAR-20-215)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): New Applications: July 20,2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023 Revision, Resubmission Applications: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
• NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
  (PAR-20-216)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): New Applications: July 20,2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023 Resubmission and Revision: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
• NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
  (PAR-20-217)
  National Center for Complementary and Integrative Health
  Office of Dietary Supplements
  Application Receipt Date(s): New Applications: July 20,2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023 Resubmission Applications: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
• NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
  (PAR-20-218)
  National Center for Complementary and Integrative Health
  Office of Dietary Supplements
  Application Receipt Date(s): New Applications: July 20,2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023 Resubmission Applications: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
• Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
  (PAR-20-219)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): New Applications: July 20,2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023 ,Resubmission and Revision Applications: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
• NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
  (RFA-DK-20-002)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 20, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
  (RFA-ES-20-012)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): August 10, 2020
• Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional)
  (RFA-HD-21-006)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 30, 2020
• NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
  (RFA-RM-20-011)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 11, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
• NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
  (RFA-RM-20-012)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): August 21, 2020 No late applications will be accepted for this Funding Opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
  (RFA-RM-20-013)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 30, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
• NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
  (RFA-RM-20-014)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 4, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
• NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)
  (RFA-RM-20-020)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 30, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
• NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional)
  (RFA-RM-20-021)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 4, 2020 No late applications will be accepted for this Funding Opportunity Announcement.